Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 19 (1), 949

Antibiotic Dispensation Rates Among Participants in Community-Driven Health Research Projects in Arctic Canada

Affiliations

Antibiotic Dispensation Rates Among Participants in Community-Driven Health Research Projects in Arctic Canada

Kathleen Williams et al. BMC Public Health.

Abstract

Background: Community-driven projects that aim to address public concerns about health risks from H. pylori infection in Indigenous Arctic communities (estimated H. pylori prevalence = 64%) show frequent failure of treatment to eliminate the bacterium. Among project participants, treatment effectiveness is reduced by antibiotic resistance of infecting H. pylori strains, which in turn, is associated with frequent exposure to antibiotics used to treat other infections. This analysis compares antibiotic dispensation rates in Canadian Arctic communities to rates in urban and rural populations in Alberta, a southern Canadian province.

Methods: Project staff collected antibiotic exposure histories for 297 participants enrolled during 2007-2012 in Aklavik, Tuktoyaktuk, and Fort McPherson in the Northwest Territories, and Old Crow, Yukon. Medical chart reviews collected data on systemic antibiotic dispensations for the 5-year period before enrolment for each participant. Antibiotic dispensation data for urban Edmonton, Alberta (average population ~ 860,000) and rural northern Alberta (average population ~ 450,000) during 2010-2013 were obtained from the Alberta Government Interactive Health Data Application.

Results: Antibiotic dispensation rates, estimated as dispensations/person-years (95% confidence interval) were: in Arctic communities, 0.89 (0.84, 0.94); in Edmonton, 0.55 (0.55, 0.56); in rural northern Alberta, 0.63 (0.62, 0.63). Antibiotic dispensation rates were higher in women and older age groups in all regions. In all regions, the highest dispensation rates occurred for β-lactam and macrolide antibiotic classes.

Conclusions: These results show more frequent antibiotic dispensation in Arctic communities relative to an urban and rural southern Canadian population.

Keywords: Antibiotic exposure; Antibiotic resistance; Arctic Canada; Helicobacter pylori; Treatment failure.

Conflict of interest statement

The authors declare that they have no competing interests.

Similar articles

See all similar articles

References

    1. Perez Aldana L, Kato M, Nakagawa S, Kawarasaki M, Nagasako T, Mizushima T, et al. The relationship between consumption of antimicrobial agents and the prevalence of primary helicobacter pylori resistance. Helicobacter. 2002;7:306–309. doi: 10.1046/j.1523-5378.2002.00096.x. - DOI - PubMed
    1. McMahon BJ, Hennessy TW, Bensler JM, Bruden DL, Parkinson AJ, Morris JM, et al. The relationship among previous antimicrobial use, antimicrobial resistance, and treatment outcomes for helicobacter pylori infections. Ann Intern Med. 2003;139:463–469. doi: 10.7326/0003-4819-139-6-200309160-00008. - DOI - PubMed
    1. Megraud F, Coenen S, Versporten A, Kist M, Lopez-Brea M, Hirschl AM, et al. Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption. Gut. 2013;62:34–42. doi: 10.1136/gutjnl-2012-302254. - DOI - PubMed
    1. Banatvala N, Davies GR, Abdi Y, Clements L, Rampton DS, Hardie JM, et al. High prevalence of helicobacter pylori metronidazole resistance in migrants to East London: relation with previous nitroimidazole exposure and gastroduodenal disease. Gut. 1994;35:1562–1566. doi: 10.1136/gut.35.11.1562. - DOI - PMC - PubMed
    1. Poon SK, Lai CH, Chang CS, Lin WY, Chang YC, Wang HJ, et al. Prevalence of antimicrobial resistance in helicobacter pylori isolates in Taiwan in relation to consumption of antimicrobial agents. Int J Antimicrob Agents. 2009;34:162–165. doi: 10.1016/j.ijantimicag.2009.02.007. - DOI - PubMed

MeSH terms

Substances

Feedback